Aspergillosis case-fatality rate: systematic review of the literature.
about
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsAntifungal therapy in infants and children with proven, probable or suspected invasive fungal infectionsBeta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropeniaAntifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance PRisk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort studyIdentification and characterization of an Aspergillus fumigatus "supermater" pairPathogenesis of Aspergillus fumigatus in Invasive AspergillosisAspergillus fumigatus: principles of pathogenesis and host defenseDoxycycline-regulated gene expression in the opportunistic fungal pathogen Aspergillus fumigatusCandida albicans genome sequence: a platform for genomics in the absence of geneticsFungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Clinical application of volatile organic compound analysis for detecting infectious diseasesMultiple Aspergillus cerebellar abscesses in a middle-aged female: case report and literature reviewTherapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveControl and manipulation of pathogens with an optical trap for live cell imaging of intercellular interactionsCrystal Structures and Small-angle X-ray Scattering Analysis of UDP-galactopyranose Mutase from the Pathogenic Fungus Aspergillus fumigatusScreening-based discovery ofAspergillus fumigatusplant-type chitinase inhibitorsAzole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?Sexual development and cryptic sexuality in fungi: insights from Aspergillus speciesComparison of echinocandin antifungalsInvasive aspergillosis in the intensive care unitAspergillus, Penicillium and Talaromyces isolated from house dust samples collected around the worldEosinophils in fungus-associated allergic pulmonary diseaseHsp90 governs dispersion and drug resistance of fungal biofilmsSCF Ubiquitin Ligase F-box Protein Fbx15 Controls Nuclear Co-repressor Localization, Stress Response and Virulence of the Human Pathogen Aspergillus fumigatusThe best of respiratory infections from the 2015 European Respiratory Society International CongressEpidemiology of invasive candidiasis: a persistent public health problemInvasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs.Deciphering chemokine properties by a hybrid agent-based model of Aspergillus fumigatus infection in human alveoli.Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related speciesIncrease in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997.Identification of essential genes in the human fungal pathogen Aspergillus fumigatus by transposon mutagenesis.Aspergillus susceptibility testing in patients with cancer and invasive aspergillosis: difficulties in establishing correlation between in vitro susceptibility data and the outcome of initial amphotericin B therapy.Characterization of essential genes by parasexual genetics in the human fungal pathogen Aspergillus fumigatus: impact of genomic rearrangements associated with electroporation of DNA.Fungal antigens expressed during invasive aspergillosisA role for the unfolded protein response (UPR) in virulence and antifungal susceptibility in Aspergillus fumigatus.Surgical management of complications of multimodal therapy.In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis
P2860
Q24201767-D76F1B39-CF50-4FB2-BB9E-5510A0E39874Q24239978-621CE865-A4FF-4281-9C52-5BED5AA65039Q24243629-8350500D-1B86-4089-A193-E6AB5BCADC04Q24248048-23CD543F-3279-4E74-8376-54DF8BAE27FAQ24535844-A44AD14A-4721-4398-A8EE-A0D664DBDD9BQ24606804-DBE03B58-DA76-4819-9156-E2E2AB43EB6CQ24633824-262D8435-211B-4D43-88B7-77E8A7627880Q24650911-91185379-088F-42A1-B670-670C507E3774Q24681995-44DD4317-440F-4955-AECF-79390243A33AQ24795519-F79F9337-F65E-49BF-8C17-08DBED33C7BCQ24805003-5113C60A-EBAA-40E7-9B64-D238C8411B95Q26740363-5C63AD86-B1EF-4DDA-B23D-109DFE799312Q26829695-5E6164D3-C714-4944-AFED-DB96E386CBF2Q26851612-8A9F8C28-BD92-4ACE-A3BB-69D839267E41Q27009221-4E988BE5-5FDB-4493-9ED4-A34E1C5AF0B6Q27313251-97CF83F8-2FB6-4BD4-A5E9-8864B9AC86F6Q27676971-A590FEFE-3082-4CEF-90E8-002236A02CCFQ27684822-209DE19E-64ED-40A6-A48D-1A88071DA025Q28082352-A7108E86-4FDE-4343-A8F0-5BD5F5DD440DQ28253241-83A02147-776A-4814-BAD6-DFAFA2865DA1Q28273738-535D072A-7AC8-43FB-81DC-352C81D1F3EEQ28306909-70C760BF-7BA4-475F-8B83-08B55473B5E3Q28383582-50579C79-7E21-48D4-BB24-56EDA462225EQ28393919-81616CC7-DDEF-4AA6-9E41-8A9C199741B3Q28476836-0D602592-808E-4B3F-8135-92F8477A5131Q28554262-B58E99DD-B459-4CC8-8946-1483B3C52CEBQ28598393-654F4187-1A0C-4D44-940B-222666D91463Q29616758-9BE9D6A5-420A-4AD5-B7D6-0481558FD5B4Q30240242-4D6ADF49-6A1F-4209-A72A-979292F22C8DQ30453001-9836996B-668B-436A-B92D-CFA5BA5A2293Q30651977-157B13D7-8C2D-4D67-8C25-32C37144358CQ30841118-93E28CBE-7FF1-46CA-A9D6-A9A9E5798E55Q30884490-897AF7EA-65CF-4CBC-95AD-0719D2B53644Q30913384-DBF01C6F-7BEE-4E44-A21F-D6DD1B2811B4Q31004718-257DBBDF-065A-49FC-8F98-F1A2AB15A7BDQ31097677-AE4D4169-0E62-456A-9F52-2587CDC25608Q33220252-6A790FA5-CCD4-4278-B023-2667EE19BD91Q33398514-0627E9F1-2B3B-4FE4-A559-52781C0E015EQ33400344-A3CC5313-2744-49FB-B96D-32052967780CQ33551044-F8A22281-83C6-494F-9E53-926E76152258
P2860
Aspergillosis case-fatality rate: systematic review of the literature.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Aspergillosis case-fatality rate: systematic review of the literature.
@ast
Aspergillosis case-fatality rate: systematic review of the literature.
@en
type
label
Aspergillosis case-fatality rate: systematic review of the literature.
@ast
Aspergillosis case-fatality rate: systematic review of the literature.
@en
prefLabel
Aspergillosis case-fatality rate: systematic review of the literature.
@ast
Aspergillosis case-fatality rate: systematic review of the literature.
@en
P2093
P2860
P356
P1476
Aspergillosis case-fatality rate: systematic review of the literature.
@en
P2093
P2860
P304
P356
10.1086/318483
P407
P577
2001-01-26T00:00:00Z